Canada - English - Health Canada

ganz inc. - octinoxate; octocrylene; oxybenzone; zinc oxide - stick - 7.5%; 7.5%; 3.5%; 1.5% - octinoxate 7.5%; octocrylene 7.5%; oxybenzone 3.5%; zinc oxide 1.5% - sunscreen agents

Australia - English - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 34925 - catheter, cardiac, balloon, thermal dilution - the swan ganz vip thermodilution catheter, including contamination shield, provides diagnostic information to rapidly determine haemodynamic pressures using bolus thermodilution measurements when used with a compatible cardiac output computer. it is a balloon tipped catheter that is inserted in a large vein and floated into the pulmonary artery. the 5 lumen catheter with a venous infusion port allows direct access to the right atrium and is made from medical grade pvc designed to soften in vivo. indicated for the assessment of a patient's haemodynamic condition through direct intracardiac and pulmonary artery pressure monitoring, cardiac output determination by bolus thermodilution, sampling of mixed venous blood and for infusing solutions. the catheter is intended to be used by clinicians in a critical care environment for critically ill patients, including paediatric patients.

United States - English - NLM (National Library of Medicine)

mayne pharma inc. - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 200 mg - because of its life-threatening side effects and the substantial management difficulties associated with its use (see “ warnings ” below), amiodarone is indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated. - recurrent ventricular fibrillation. - recurrent hemodynamically unstable ventricular tachycardia. as is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of amiodarone favorably affects survival. amiodarone should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating recurrent life-threatening ventricular arrhythmias, and who have access to appropriate monitoring facilities, including in-hospital and ambulatory continuous electrocardiographic monitoring and electrophysio

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 200 mg - because of its life-threatening side effects and the substantial management difficulties associated with its use (see warnings   below), amiodarone hydrochloride tablets are indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated. 1. recurrent ventricular fibrillation. 2. recurrent hemodynamically unstable ventricular tachycardia. as is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of amiodarone hydrochloride tablets favorably affects survival. amiodarone hydrochloride tablets should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating recurrent life-threatening ventricular arrhythmias, and who have access to appropriate monitoring facilities, including in-hospital and ambul

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 200 mg - because of its life-threatening side effects and the substantial management difficulties associated with amiodarone use (see "warnings" below), pacerone® (amiodarone hcl) tablets are indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated. - recurrent ventricular fibrillation. - recurrent hemodynamically unstable ventricular tachycardia. as is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of amiodarone hcl tablets favorably affects survival. pacerone® (amiodarone hcl) tablets should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating recurrent life-threatening ventricular arrhythmias, and who have access to appropriate monitoring facilities, including in-hospital and amb

United States - English - NLM (National Library of Medicine)

ncs healthcare of ky, inc dba vangard labs - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - because of its life-threatening side effects and the substantial management difficulties associated with its use (see warnings below), amiodarone is indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated. - recurrent ventricular fibrillation. - recurrent hemodynamically unstable ventricular tachycardia. as is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of amiodarone hydrochloride tablets favorably affects survival. amiodarone should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating recurrent life-threatening ventricular arrhythmias, and who have access to appropriate monitoring facilities, including in-hospital and ambulatory continuous electrocardiographic monitoring

Australia - English - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 35854 - catheter, cardiac, balloon, pacing electrode - the swan-ganz bipolar pacing catheters are designed for temporary right ventricular endocardial pacing. a distal balloon facilitates insertion by flow-direction. a pair of electrodes at the tip provides capabilities for bipolar pacing and electromagnetic monitoring.the catheter has a ?j-tip? configuration for femoral insertion to predispose the catheter to a stable pacing position in the apex of the right ventricle. the swan-ganz bipolar pacing catheters are indicated for use in temporary, transvenous right ventricular pacing.

Australia - English - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 35854 - catheter, cardiac, balloon, pacing electrode - the swan-ganz bipolar pacing catheters are designed for temporary right ventricular endocardial pacing. a distal balloon facilitates insertion by flow-direction. a pair of electrodes at the tip provides capabilities for bipolar pacing and electromagnetic monitoring. the swan-ganz bipolar pacing catheters are indicated for use in temporary, transvenous right ventricular pacing.

Australia - English - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 35854 - catheter, cardiac, balloon, pacing electrode - swan ganz pacing-td catheters serve as diagnostic and therapeutic tools in the management of critically ill patients. the pacing-td catheter can perform right artrial, pulmonary arterial and pulmonary artery occlusion pressure measurements, blood sampling, solution infusion, and cardiac output measurements by thermodilution when used with a compatible cardiac output computer. it consists of a distal port, injectate port, inflation port and thermistor, and is made from pvc with a latex balloon. the swan-ganz pacing-td catheter is indicated for atrial, ventricular, or a-v sequential pacing for hemodynamic reasons, overdrive suppression of atrial or ventricular arrhythmias, and diagnosis of complex arrhythmias.

United States - English - NLM (National Library of Medicine)

mckesson rxpak inc - amiodarone hydrochloride (unii: 976728sy6z) (amiodarone - unii:n3rq532iut) - amiodarone hydrochloride 200 mg - because of its life-threatening side effects and the substantial management difficulties associated with its use (see "warnings" below), pacerone® (amiodarone hcl) tablets are indicated only for the treatment of the following documented, life-threatening recurrent ventricular arrhythmias when these have not responded to documented adequate doses of other available antiarrhythmics or when alternative agents could not be tolerated. - recurrent ventricular fibrillation. - recurrent hemodynamically unstable ventricular tachycardia. as is the case for other antiarrhythmic agents, there is no evidence from controlled trials that the use of amiodarone hcl tablets favorably affects survival. pacerone® (amiodarone hcl) tablets should be used only by physicians familiar with and with access to (directly or through referral) the use of all available modalities for treating recurrent life-threatening ventricular arrhythmias, and who have access to appropriate monitoring facilities, including in-hospital and ambulatory